How much funding has Codexis raised?

Codexis has raised $87.0M in total funding, most recently a corporate round round.

Who are Codexis's investors?

Codexis's investors include Casdin Capital, Credit Suisse, Pequot Capital Management, CMEA, Piper Jaffray, RBC Capital Markets.

Where is Codexis headquartered?

Codexis is headquartered in Redwood City, California, United States.

What industry is Codexis in?

Codexis operates in Biotech, Manufacturing.

Codexis

IPO

RNA Manufacturer | Enzyme Biocatalysis Solutions

Public · Redwood City, United States · Founded 2002 · $87.0M raised

Biotech

Manufacturing

Headquarters: Redwood City, California
Employees: 201–500
Founded: 2002
Business Model: B2B
Website: codexis.com

Total Funding: $87.0M
Last Round: $50.0M Corporate RoundJun 2019
Rounds: 3
Type: Public

About

Enzyme engineering company providing biocatalysis solutions for pharmaceutical manufacturing, including siRNA therapeutics.

Summary

Codexis is a Biotech company based in Redwood City, United States, founded in 2002. It has raised $87.0M in total across 3 rounds, most recently a $50.0M Corporate Round round in Jun 2019. Investors include Casdin Capital, Credit Suisse and Pequot Capital Management.